Valneva SE current report, Q2 FY2023

Filing Overview

Valneva SE filed Form 6-K on May 31, 2023, as a foreign private issuer reporting under Form 20-F. The filing covers press releases dated May 30 and May 31, 2023, which were furnished as Exhibits 99.1, 99.2, and 99.3.

Business Context and Reporting Period

The filing does not present a defined quarterly or annual reporting period. It incorporates the attached press releases into Valneva’s Form F-3 registration statement (File No. 333-266839).

Financial and Operating Metrics

The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. The contents of Exhibits 99.1, 99.2, and 99.3 are not included in the supplied text.

Material Changes, Outlook, and Risks

The filing itself does not describe material changes versus a prior comparable period, guidance, outlook, management commentary, risks, contingencies, or unusual items. These matters may be addressed in the referenced press releases, which should be reviewed separately.

Important Investor Verification Items

  • Obtain and review Exhibits 99.1, 99.2, and 99.3 for the substantive announcements.
  • Verify whether the press releases contain financial results, clinical or regulatory developments, commercial updates, or revised guidance.
  • Assess any material information incorporated by reference into Valneva’s Form F-3 registration statement.
  • Confirm the date, scope, and implications of each May 30 and May 31, 2023 press release.